The intervention showed no clear difference in all‐cause mortality (low certainty).
It is very uncertain whether sclerotherapy changes all‐cause mortality compared with no intervention (very low certainty).
It is very uncertain whether duodenal stenting changes all‐cause mortality compared with surgical palliation (very low certainty).
Heparin showed no clear difference in neonatal mortality (all‐cause) compared with placebo/no treatment (low certainty).
It is very uncertain whether erythromycin changes all‐cause mortality compared with nasogastric tube lavage (very low certainty).
It is very uncertain whether portosystemic shunts changes all‐cause mortality compared with endoscopic intervention with or without medical treatment (very low certainty).
It is very uncertain whether distal splenorenal shunt changes all‐cause mortality compared with endoscopic intervention (very low certainty).
It is very uncertain whether transjugular intrahepatic portosystemic shunt changes all‐cause mortality compared with endoscopic intervention with or without medical treatment (very low certainty).
It is very uncertain whether total shunt changes all‐cause mortality compared with endoscopic intervention (very low certainty).
The review found no eligible studies for this question.
Summary of findings table ‐ routine monitoring showed no clear difference in all‐cause mortality before hospital discharge compared with no routine monitoring of gastric residual (low certainty).
Summary of findings table ‐ Re‐feeding showed no clear difference in all‐cause mortality before hospital discharge compared with discarding gastric residuals (low certainty).
It is very uncertain whether antithrombin changes neonatal mortality (all‐cause, < 28 days of age) compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether surgical portosystemic shunts changes all‐cause mortality compared with devascularisation with splenectomy (very low certainty).
The intervention showed no clear difference in all‐cause mortality Median (low certainty).
It is very uncertain whether pentoxifylline with antibiotics (any dose or duration) changes all‐cause mortality during hospital stay compared with immunoglobulin M‐enriched intravenous immunoglobulin with antibiotics (very low certainty).
It is very uncertain whether pentoxifylline with antibiotics (any dose or duration) changes all‐cause mortality during hospital stay compared with pentoxifylline with antibiotics and immunoglobulin M‐enriched… (very low certainty).